These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26564154)

  • 1. Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.
    Brojer E; Husebekk A; Dębska M; Uhrynowska M; Guz K; Orzińska A; Dębski R; Maślanka K
    Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):279-90. PubMed ID: 26564154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
    Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
    Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
    Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
    BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
    Bonstein L; Haddad N
    Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
    Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
    J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
    Alm J; Duong Y; Wienzek-Lischka S; Cooper N; Santoso S; Sachs UJ; Kiefel V; Bein G
    Br J Haematol; 2022 Jul; 198(1):14-23. PubMed ID: 35383895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
    Kjeldsen-Kragh J; Ni H; Skogen B
    Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
    Serrarens-Janssen VM; Semmekrot BA; Novotny VM; Porcelijn L; Lotgering FK; Delemarre FM; Steegers EA
    Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.
    Curtis BR
    Br J Haematol; 2015 Dec; 171(5):671-82. PubMed ID: 26344048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.
    Skogen B; Killie MK; Kjeldsen-Kragh J; Ahlen MT; Tiller H; Stuge TB; Husebekk A
    Expert Rev Hematol; 2010 Oct; 3(5):559-66. PubMed ID: 21083473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - New insights from a large prospective screening study in Poland.
    Coucheron T; Uhrynowska M; Guz K; Orzińska A; Debska M; Gierszon A; Ahlen MT; Bertelsen EL; Berge G; Husebekk A; Brojer E; Tiller H
    J Reprod Immunol; 2023 Dec; 160():104168. PubMed ID: 37992463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and prevention of alloimmunization in pregnancy.
    Kjeldsen-Kragh J; Skogen B
    Obstet Gynecol Surv; 2013 Jul; 68(7):526-32. PubMed ID: 23803755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.